⚕ GalenOps CRO console
← 706 (USA)

706-1041

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 706 (USA) (Dr. Rossi) · consented 2013-12-31
Adverse events
9
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

moderate assessed 2026-08-18

Moderate ANXIETY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-05; relationship: REMOTE

mild assessed 2026-08-18

Mild ANXIETY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-05; relationship: REMOTE

mild assessed 2026-08-18

Mild DIARRHOEA — outcome: RECOVERED/RESOLVED; onset 2014-01-07 (study day 8.0); relationship: REMOTE

mild assessed 2026-08-18

Mild EXCORIATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-14 (study day 15.0); relationship: NONE

mild assessed 2026-08-18

Mild EXCORIATION — outcome: RECOVERED/RESOLVED; onset 2014-01-14 (study day 15.0); relationship: NONE

moderate assessed 2026-08-18

Moderate IRRITABILITY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-15 (study day 16.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate IRRITABILITY — outcome: RECOVERED/RESOLVED; onset 2014-01-15 (study day 16.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-04 (study day 64.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild PRURITUS — outcome: RECOVERED/RESOLVED; onset 2014-03-04 (study day 64.0); relationship: POSSIBLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.